https://www.merckclinicaltrials.com/trial/nct05139017/?lang=en-ca
A Study of Zilovertamab Vedotin in Combination With Standard of Care in Participants With Relapsed...
Feb 4, 2025 - The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of...
a studyzilovertamab vedotin
https://www.merckclinicaltrials.com/trial/nct05139017/?lang=en-ca
A Study of Zilovertamab Vedotin in Combination With Standard of Care in Participants With Relapsed...
Feb 4, 2025 - The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of...
a studyzilovertamab vedotin